Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. - Wikidata - awgldk - TriplyDB

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

http://www.wikidata.org/entity/Q37388802

about

Sendai virus infection induces efficient adaptive immunity independently of type I interferons Pathogen recognition and inflammatory signaling in innate immune defenses Macrophages and cytokines in the early defence against herpes simplex virus Innate immune responses to DNA viruses A Novel Toll-Like Receptor (TLR) Influences Compatibility between the Gastropod Biomphalaria glabrata, and the Digenean Trematode Schistosoma mansoni Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history Cytoplasmic DNA innate immune pathways Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9 Nucleic acid scavenging polymers inhibit extracellular DNA-mediated innate immune activation without inhibiting anti-viral responses An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons The virion host shut-off (vhs) protein blocks a TLR-independent pathway of herpes simplex virus type 1 recognition in human and mouse dendritic cells.Innate immune recognition of viruses and viral vectors.Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.MyD88-dependent pro-interleukin-1β induction in dendritic cells exposed to food-grade synthetic amorphous silica.Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain Involvement of TLR2 and TLR4 in cell responses to Rickettsia akari UNC93B1 mediates innate inflammation and antiviral defense in the liver during acute murine cytomegalovirus infection.Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells CD200R1 supports HSV-1 viral replication and licenses pro-inflammatory signaling functions of TLR2.Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.Toll-like receptor-independent triggering of dendritic cell maturation by viruses.In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and Ikappa B kinase.Mesenchymal stem cells detect and defend against gammaherpesvirus infection via the cGAS-STING pathway.Novel drugs targeting Toll-like receptors for antiviral therapy.Optimization of allergen standardization Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections.

P2860

Q24545838-50240D05-311C-4CBD-8064-FDC9DD6675DF Q24643034-EA8DC779-9635-40AE-B898-6031993266CC Q24815062-947AF68C-3AA3-4DA0-9F47-95109182D856 Q27027584-48931955-A485-49BD-992E-65DA9869BACF Q27315002-663CBCC0-10E1-40D6-B506-2DC903634C12 Q27318346-30757C5E-3E72-404F-8E2D-8584857A2E2E Q27478142-5CC182B5-AFB3-488E-B806-61D90A364151 Q27485637-2CF2567A-EB6D-4A2B-B2B4-FC555E865E8D Q28246926-7AF3A91C-C473-4BDF-9ED3-DE91E3AD63F8 Q28303382-F14EEA87-6DCF-431D-B4B7-1DDF5FD48C1C Q28504793-5E2CD4CE-F40E-4428-A367-9F2DA0CAACC2 Q28507728-FB57D8D2-2FF7-4C45-8D56-E5B6AB11262A Q28534779-91FCDF88-A3A1-4CE9-8F5F-E8EA8EC57410 Q28590087-52A6A4B4-BA14-4A2A-9730-66DB9FB9D561 Q30179408-E3AC805F-6700-450D-9F44-888BAE6A842C Q30371866-5E25F32D-C980-46A6-B205-A60E23FE73BA Q30499869-EC9A613C-01BE-4FBB-8904-608364DFAF7C Q33533335-FAF3C860-4028-472B-B469-CDFA8707165C Q33805229-2ED4E6CE-947E-4900-8A74-9D3CA810E8EB Q33805319-E50FF147-64FC-4B00-B8B7-795C7347B555 Q33827649-C4FB696D-9814-4347-B2B9-B5DCCB28E3E1 Q33911908-3F04E4B8-1966-4F9A-BEC4-B496E0E5331F Q34048648-C64A9027-72D3-4BD6-89B0-C7A7B409FFF2 Q34078687-50185D5D-64F0-47A8-8551-55DA46487A8B Q34105712-CD58468A-7625-48C6-ACBA-A221CF147451 Q34254496-E88C3DA3-81E4-4244-BF23-84029CCBA6A8 Q34273718-7FBBC4CE-023D-4157-819C-651B48974199 Q34281709-AE986B2A-F3FF-4991-903C-885D81252D20 Q34314248-C067BA52-B343-4C52-9F66-165EA1C368D4 Q34434660-E1FCA9A0-9817-4187-9F39-08DF91B4C997 Q34452244-04789200-D27F-4896-8653-9C6C425CF359 Q34479875-68870EA9-3781-4EA5-BDF0-584AB4261977 Q34545693-03CA60C5-2BE6-4DCD-803E-87EEF717448F Q34545982-51589D7D-B73E-47E2-AA52-50A43502B009 Q34594898-1D2F0D21-86B9-4714-A038-07EFDAB58453 Q34742621-20B7D176-39E2-48A8-8C60-66E34F090AD1 Q34975235-4594D415-8B84-44FE-B462-C2559DD07216 Q34999938-7E60929E-561D-4A25-85FF-C8A188D90AF7 Q35003417-B31271F7-B5F6-4AA6-B88A-13C7249CB47A Q35034249-BFA56B17-930E-406C-84E9-0398315295B5

P2860

Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

http://www.wikidata.org/entity/Q37388802

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 July 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@en

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@nl

type

label

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@en

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@nl

prefLabel

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@en

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@nl

P1433

Q37388802-729BB3D0-662A-4D53-B52D-904891CC17D5

P1476

Q37388802-09250936-4BA2-4A87-92E1-A24CE4B064D8

P2093

Q37388802-2D171BAE-8039-4E2F-B27B-20C19EEB001E

Q37388802-2E198EE5-BF1C-4978-AEED-DB8A2A81ED82

Q37388802-4E3E671B-DBD1-46A4-9B73-71601C5BFFF8

Q37388802-542CA95D-8D24-4660-A0A4-84F7D119FFD1

Q37388802-94A4D126-2F27-4DD3-AB7B-66C09B2C440C

Q37388802-AD52C025-83F0-4015-9124-A8EEDD0DE2D9

Q37388802-BEDDA315-26BA-46FA-9A34-18255A8C5705

Q37388802-DB35CE27-7818-4DB7-A4D2-788414FB6142

Q37388802-E2856270-3D68-4D81-A930-23FECB23870C

P2860

Q37388802-07238E1F-9D46-49D9-A333-0D3B9D4ADCFF

Q37388802-0FA55195-EA31-4034-813D-CB6CEA220EF8

Q37388802-0FB6E4E5-B340-40E1-A759-3B45831D7FC3

Q37388802-1110FDDB-F84E-4641-9C49-3E71898FBA3E

Q37388802-120632C9-E4EE-4D3D-B5A8-DFEBC9767867

Q37388802-12E64789-13D2-49D5-AA50-B0CC0B485099

Q37388802-318E8F9C-D2EF-4C97-BA2A-8B288D0B6A96

Q37388802-34C75404-4CF2-4D6C-8B0D-D8232234B15E

Q37388802-3D8C4DAC-506E-4592-B516-D10518A0D541

Q37388802-476E18AC-A3AF-4B1E-B930-758112191F58

P304

Q37388802-688AAC58-EFEB-4E6F-8768-6B388F627440

P31

Q37388802-7D3DE967-EDDC-4B67-8C38-5A2D5E368071

P356

Q37388802-E502577C-6F40-433E-9463-DB967C14263F

P407

Q37388802-E74673CA-0644-41A6-A566-DDA2D11D0A98

P433

Q37388802-E65064B4-9B64-4AA6-806B-E07C2D1E70EB

P478

Q37388802-B4260EFB-CF44-4E5B-B05B-B170FBA76DFE

P577

Q37388802-0FD6D202-3A9E-44AD-8044-DB21BB06ECE1

P5875

Q37388802-25DBFBAA-E525-422F-836E-3158F3C96FBD

P698

Q37388802-B963879E-BF75-4700-ACDD-EBAFC2FC7A39

P921

Q37388802-1B70D37D-0F07-4558-A1F1-1A361BC9A790

Q37388802-827FD7CD-30D5-4634-8FF5-05B672805A63

P932

Q37388802-03387DCD-8F85-4FDE-A5FB-449C464D7955

P356

PNAS.0403555101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Herpes simplex virus type-1 in ...... ent and -independent pathways.

@en

P2093

Beatrix Schlatter

http://www.w3.org/2001/XMLSchema#string

Cornelia Wagner

http://www.w3.org/2001/XMLSchema#string

Frank Schmitz

http://www.w3.org/2001/XMLSchema#string

Hermann Wagner

http://www.w3.org/2001/XMLSchema#string

Hubertus Hochrein

http://www.w3.org/2001/XMLSchema#string

Mark Suter

http://www.w3.org/2001/XMLSchema#string

Matthias Schiemann

http://www.w3.org/2001/XMLSchema#string

Meredith O'Keeffe

http://www.w3.org/2001/XMLSchema#string

Stefan Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus

Murine retroviruses activate B cells via interaction with toll-like receptor 4

DNA containing CpG motifs induces angiogenesis.

Toll meets bacterial CpG-DNA.

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

Mouse and human dendritic cell subtypes.

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

P304

11416-11421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0403555101

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8437766

http://www.w3.org/2001/XMLSchema#string

P698

15272082

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

509215

http://www.w3.org/2001/XMLSchema#string